NCT04007029 2025-09-05Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaJonsson Comprehensive Cancer CenterPhase 1 Active not recruiting24 enrolled